Thursday, May 7, 2026

H.R. 8500: Ensuring Timely LCDs! The Bill's Language is Posted!

HEADER: Last week, CAP and some Congressionial offices announced H.R.8500, the "Timely Access to Coverage Decisions Act."  Here.  The legislative language is now posted!  Find the full text of the bill here.

###

AI Corner Chat GPT

##

Timely Access to Coverage Decisions Act of 2026 — What It Would Do

TLDR — The bill would put a clock on the Medicare LCD process. When a MAC receives a formal LCD request or reconsideration request, it would have 60 days to say whether the request is complete. If incomplete, the MAC must identify what is missing. If complete, the MAC must act within one year. The bill also strengthens the public draft-LCD process: open meetings, remote access, expert input, posted meeting records, public comments, written responses, and a requirement that the final LCD be a logical outgrowth of the draft.

##

A new House bill, the Timely Access to Coverage Decisions Act of 2026, would put firmer timelines and procedural guardrails around how Medicare Administrative Contractors handle Local Coverage Determinations — the LCDs that decide whether Medicare will cover many services, tests, procedures, and technologies in a MAC region. The bill was introduced  in April 2026, by Rep. Neal Dunn of Florida, with Reps. Nanette Barragán and Claudia Tenney as cosponsors.

In practical terms, the bill tries to solve a familiar problem: an innovator, physician group, lab, manufacturer, or other stakeholder can ask a MAC for a coverage decision, but the request may sit for a long time with no clear endpoint. This legislation would not guarantee a favorable LCD. But it would require the MAC to say whether the request is complete, identify what is missing if it is not complete, and act within a defined time period if it is complete.


The Bill in Plain English

The bill creates a 60-day completeness review. When a MAC receives a formal LCD request, it would have 60 days to decide whether the request is complete or incomplete. If the request is incomplete, the MAC would have to send a written notice listing the missing items. This is important because it prevents the request from disappearing into a fog of informal “not enough information” objections.

For a complete formal New LCD request, the MAC would have to act within one year. The bill doesn't say that the MAC must issue a positive LCD. Rather, it must move through the LCD process and take the required actions for a decision. In other words, the MAC still has discretion on coverage, but not indefinite discretion on timing.

The same structure would apply to LCD Reconsideration requests. The MAC gets 60 days to review, a year to finalize. LCD revisions can be just as important as new LCDs. A technology may already be addressed in an LCD, but in a way that is outdated, too narrow, or inconsistent with new evidence.

The bill defines who can bring these requests. An interested party includes Medicare beneficiaries in the affected area, providers or suppliers furnishing the relevant services in that area, and other entities the Secretary recognizes. This brings current manual language into statute.

One of the more interesting provisions creates a path for agency review of a MAC’s reconsideration decision

If an interested party requests it, the Secretary would review the MAC’s final determination after a complete reconsideration request. The bill gives several grounds for review, including whether the MAC misread or failed to apply relevant evidence, used language broader than necessary, made an incorrect reasonable-and-necessary determination, failed to describe the clinical conditions for coverage, failed to apply the LCD to the services it was meant to address, or conflicted with another law, rule, regulation, or national coverage determination.

That section is potentially significant. The LCD is not a dead-end.  Ask CMS to review whether the MAC’s decision was evidence-based, properly scoped, and legally consistent.

The bill also rewrites and expands the process for issuing certain LCDs. For new LCDs, substantive LCD revisions, and any other LCDs specified by CMS, the MAC would have to publish a draft LCD, related coding or billing information, a rationale, and a description of evidence considered. The draft would have to appear on both the Medicare Coverage Database and the MAC’s own website. Again, this mostly transfers current manual language to statute.

Within 60 days after publishing the draft LCD, the MAC would have to hold one or more open public meetings, allow remote attendance, publish an agenda at least 14 days in advance, receive comments, and obtain advice from an expert panel. That panel must include at least one physician, at least one Contractor Advisory Committee member, and at least one patient-advocacy entity.

The bill also adds a recordkeeping requirement. After each public meeting, the MAC would have to post a record of the meeting within 14 days. That record could include audio or video. Then the MAC must provide a written public comment period of at least 30 days, beginning after the meeting records are posted.  This procedure is new.

For final LCDs, the MAC would have to post the response to public comments, the full text of comments received, the rationale for the final LCD, any newly submitted qualifying evidence considered.  

The bill also adds a “logical outgrowth” requirement: the final LCD cannot take effect unless it is a logical outgrowth of the draft LCD. In plain English, the MAC should not float one policy in draft form and then finalize something materially different without proper notice.  (Some LCDs in recent years have been revoked due to the "logical outgrowth" principal.  This is a general principal in administrative law or rulemaking.  At SSA 1871(a)(4) there is a clause restricting CMS rule changes to "logical outgrowths" of proposals.)

Final LCDs become effective in 45 days after posting, as is current policy.

The bill defines qualifying evidence as publicly available evidence of general acceptance by the medical community. Examples include peer-reviewed original research, systematic reviews, meta-analyses, evidence-based consensus statements, and clinical guidelines.  I read this as helpful.

Why This Matters

For companies, labs, physician groups, and patient advocates, the bill’s core value is not that it creates automatic coverage. It does not. Its value is that it creates process discipline. It would force a MAC to identify missing information, move complete requests along, and explain its reasoning more transparently.

For emerging technologies, this matters because the LCD process can be a bottleneck. A test, device, or procedure may have growing evidence and clinical support, but without an LCD or LCD revision, coverage may remain uncertain or inconsistent. The bill tries to turn an open-ended administrative process into a more predictable one.

The practical takeaway: this bill is an LCD clock bill, a transparency bill, and a procedural accountability bill. It does not tell MACs what to cover. But it tells them they cannot leave formal LCD requests and reconsideration requests in limbo indefinitely.